Proteomics International Laboratories Ltd (ASX:PIQ) Promarke

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce a major milestone in the commercialisation of its predictive test for diabetic kidney disease, PromarkerD, with the US Centers for Medicare & Medicaid Services.

Related Keywords

Australia , Perth , Western Australia , United States , American , Americans , Australian , Richard Lipscombe , Australian Therapeutic Goods Administration , American Medical Association , Us Centers For Medicare Medicaid Services , Medicare Advisory Panel On Clinical Diagnostic Laboratory , Proteomic International , Cptr Proprietary Laboratory Analyses , Proteomics International , Proteomics International Laboratories Ltd , Janssen Research Development , Centers For Medicare Medicaid Services , Laboratory Developed Test , Therapeutic Goods Administration Australia , Proteomics International Laboratories , Reimbursement Price , Aus Regulatory , International Laboratories Ltd , Medicaid Services , Sonic Healthcare United States , Medicare Advisory Panel , Clinical Diagnostic Laboratory Tests , Proprietary Laboratory Analyses , Goods Administration , Australian Register , Therapeutic Goods , Developed Test , Janssen Research , International Laboratories , Biotech , Health Pharm Generalproteomics International Laboratories Ltd , Asx Piq ,